期刊文献+

阿司匹林作用下子宫内膜腺癌细胞凋亡与Bcl-xl蛋白表达的关系 被引量:1

Relationship between Apoptosis and Bcl-xl Protein Expression of Endometrial Adenocarcinoma Cells Treated with Aspirin
原文传递
导出
摘要 目的:探讨阿司匹林作用下人子宫内膜腺癌Ishikawa细胞凋亡率与凋亡抑制蛋白Bcl-xl表达变化的关系。方法:应用流式细胞仪(FCM)检测不同浓度阿司匹林对子宫内膜腺癌Ishikawa细胞周期和凋亡率的影响;Westernblotting法检测阿司匹林对Bcl-xl蛋白表达的影响。结果:①阿司匹林引起细胞阻滞在G1期,细胞凋亡率增加,与药物作用浓度相关(P<0.05);②阿司匹林降低Bcl-xl蛋白的表达,与药物作用浓度相关(P<0.05);③Ishikawa细胞凋亡率与Bcl-xl蛋白的表达水平存在负相关关系(r=-0.873,P<0.05)。结论:Bcl-xl蛋白在阿司匹林促进子宫内膜腺癌细胞凋亡的调控中起到重要的作用。 Objective: To study the relationship between aspirin induced apoptosis rates and the expression of Bcl-xl protein in endometrial adenocarcinoma Ishikawa cells. Methods: Flow cytometry (FCM) was used to examine the distribution of cell cycles and the rates of cell apoptosis. Western blotting was used to evaluate the expression of Bcl-xl protein. Results: 1) Aspirin increased the distribution of G1 and the rates of cell apoptosis in a dose-dependent manner (P〈0.05). 2) Aspirin decreased the expression of Bcl-xl protein in a dose-dependent manner (P〈0.05). 3) The apoptosis rates of Ishikawa cells were negatively linearly related to the expression of Bcl- xl protein (r =- 0.873, P〈0.05). Conclusion: Bcl-xl protein may play an important role in the apoptosis of Ishikawa cells induced by aspirin.
出处 《生殖与避孕》 CAS CSCD 北大核心 2009年第10期657-660,共4页 Reproduction and Contraception
基金 辽宁省教育厅高等学校科学技术研究项目(05L477)
关键词 阿司匹林 ISHIKAWA细胞 凋亡 BCL-XL蛋白 aspirin Ishikawa cells apoptosis Bcl-xl
  • 相关文献

参考文献3

二级参考文献26

  • 1刘萱,李鹏,张澍田,贾继东,于中麟.食管鳞癌中COX-2 mRNA的表达以及NSAID对其的影响[J].世界华人消化杂志,2004,12(11):2527-2530. 被引量:4
  • 2许多,朱伟杰,王自能,秦达念.大鼠睾丸局部热作用对生精细胞Bcl-2及Bax蛋白表达的影响[J].生殖与避孕,2005,25(5):268-271. 被引量:15
  • 3林建华.卵巢自身免疫对生殖的影响[J].国外医学(计划生育分册),1995,14(4):193-195. 被引量:18
  • 4刘伯齐,姜晶梅,陈铮鸣,陈君石,张孔来,曾宪嘉,赵平,Jillian Boreham,武燕平,黎均耀,Richard Peto.中国103个地区吸烟与食管癌风险研究:死因调查中的病例对照方法学研究[J].中华医学杂志,2006,86(6):380-385. 被引量:24
  • 5李洁,杨菁.卵巢早衰动物模型建立的研究进展[J].生殖与避孕,2006,26(9):550-553. 被引量:16
  • 6Chiaffarino F, Parazzini F, Paladini D, et al. A small randomised trial of low-dose aspirin in women at high risk of pre-eelampsia[ J]. Eur J Obstet Gynecol Reprod Biol, 2004, 112 (2): 142-144.
  • 7Tarim E, Bal N, Kilicdag E, et al. Effects of aspirin on placenta and perinatal outcomes in patients with poor obstetric history [ J]. Arch Gyneeol Obstet, 2006, 274(4): 209-214.
  • 8Kalinka J, Gottwald L, Nowakowski M, et al. The impact of lowdose aspirin therapy on umbilical and middle cerebral artery blood flow in pregnancy complicated by idiopathic intrauterine growth restriction[J]. Ginekol Pol, 2004, 75(4): 254-260.
  • 9Boog G, Le VaiUant C, Alnoukari F, et al. Combining corticosteroid and aspirin for the prevention of recurrent villitis or intervillositis of unknown etiology[J]. J Gynecol Obstet Biol Reprod (Paris), 2006, 35(4): 396-404.
  • 10Noble LS, Kutteh WH, Lashey N, et al. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecularweight heparin versus unfractionated heparin [J]. Fertil Steril, 2005, 83(3): 684-690.

共引文献57

同被引文献18

  • 1林其德.子癎前期子癎病因及发病机制的研究进展[J].中国实用妇科与产科杂志,2004,20(10):577-579. 被引量:71
  • 2胡乔飞,李坚.遗传性血栓形成倾向与反复自然流产的研究进展[J].生殖与避孕,2006,26(10):610-617. 被引量:17
  • 3Wallenburg HC,Dekker GA,Makovitz JW,et al.Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae.Lancet,1986,1(8471):1-3.
  • 4Spitz B,Magness R,Cox SM,et al.Low-dose aspirin.I.Effect on angiotensin II pressor responses and blood prostaglandin concentrations in pregnant women sensitive to angiotensin II.Am J Obstet Gynecol,1988,159(5):1035-43.
  • 5Gum PA,Kottke-Marchant K,Poggio ED,et al,Profile and prevalence of aspirin resistance in patients with cardiovas-cular disease.Am J Cardiol,2001,88(3):230-5.
  • 6Rey E,Rivard GE.Is testing for aspirin response worthwhile in high-risk pregnancy?Eur J Obstet Gynecol Reprod Biol,2011,157(1):38-42.
  • 7Sanchez-Ramos L,O’Sullivan MJ,Garrido-Calderon J.Ef-fect of low-dose aspirin on angiotensin II pressor response in human pregnancy.Am J Obstet Gynecol,1987,156(1):193-4.
  • 8Bujold E,Roberge S,Lacasse Y,et al.Prevention of preec-lampsia and intrauterine growth restriction with aspirin started in early pregnancy:a meta-analysis.Obstet Gynecol,2010,116(2Pt1):402-14.
  • 9Duley L,Henderson-Smart DJ,Meher S,et al.Antiplatelet agents for preventing pre-eclampsia and its complications.Cochrane Database Syst Rev,2007(2):CD004659.
  • 10Bujold E.Prevention of pre-eclampsia with low-dose aspirin.J Postgrad Med,2011,57(2):89-90.

引证文献1

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部